Rainbow Childrens Medicare Limited
Rainbow Childrens Medicare Limited (RAINBOW) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Healthcare›Healthcare›Healthcare Services›Hospital
rainbowhospitals.in(opens the company website in a new tab)Key metrics
Price as of 2026-09-03
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 333 Cr | 336 Cr | 341 Cr | 330 Cr | 417 Cr | 398 Cr | 370 Cr | 353 Cr | 445 Cr | 445 Cr | 460 Cr | 470 Cr |
| Operating expenses (approx.) | 215 Cr | 218 Cr | 236 Cr | 236 Cr | 270 Cr | 264 Cr | 255 Cr | 249 Cr | 296 Cr | 298 Cr | 315 Cr | 335 Cr |
| EBITDA | 118 Cr | 118 Cr | 106 Cr | 94 Cr | 147 Cr | 134 Cr | 115 Cr | 104 Cr | 149 Cr | 147 Cr | 145 Cr | 135 Cr |
| OPM % | 35.3% | 35.1% | 30.9% | 28.4% | 35.2% | 33.8% | 31.0% | 29.4% | 33.5% | 33.0% | 31.5% | 28.6% |
| Other income | 8 Cr | 9 Cr | 13 Cr | 12 Cr | 11 Cr | 13 Cr | 15 Cr | 20 Cr | 8 Cr | 11 Cr | 5 Cr | 13 Cr |
| Interest | 13 Cr | 14 Cr | 17 Cr | 18 Cr | 18 Cr | 18 Cr | 18 Cr | 18 Cr | 19 Cr | 20 Cr | 20 Cr | 21 Cr |
| Depreciation | 27 Cr | 28 Cr | 32 Cr | 34 Cr | 35 Cr | 35 Cr | 34 Cr | 34 Cr | 36 Cr | 40 Cr | 41 Cr | 42 Cr |
| Profit before tax | 85 Cr | 85 Cr | 69 Cr | 53 Cr | 105 Cr | 94 Cr | 77 Cr | 71 Cr | 102 Cr | 98 Cr | 87 Cr | 84 Cr |
| Tax % | 25.9% | 26.2% | 26.2% | 25.5% | 25.0% | 26.9% | 26.5% | 24.6% | 26.1% | 24.4% | 9.9% | 25.5% |
| Net profit | 63 Cr | 63 Cr | 51 Cr | 40 Cr | 79 Cr | 69 Cr | 57 Cr | 54 Cr | 76 Cr | 74 Cr | 78 Cr | 63 Cr |
| EPS (₹) | ₹6.20 | ₹6.12 | ₹5.02 | ₹3.89 | ₹7.77 | ₹6.76 | ₹5.55 | ₹5.27 | ₹7.41 | ₹7.14 | ₹7.59 | ₹5.97 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
| Sales | 974 Cr | 1,174 Cr | 1,297 Cr | 1,516 Cr | 1,703 Cr | Sign in for TTM |
| Operating expenses (approx.) | 669 Cr | 777 Cr | 868 Cr | 1,026 Cr | 1,159 Cr | Sign in for TTM |
| EBITDA | 305 Cr | 396 Cr | 429 Cr | 490 Cr | 544 Cr | Sign in for TTM |
| OPM % | 31.3% | 33.8% | 33.1% | 32.3% | 32.0% | Sign in for TTM |
| Other income | 19 Cr | 31 Cr | 37 Cr | 51 Cr | 44 Cr | Sign in for TTM |
| Interest | 53 Cr | 55 Cr | 59 Cr | 72 Cr | 78 Cr | Sign in for TTM |
| Depreciation | 83 Cr | 90 Cr | 112 Cr | 138 Cr | 151 Cr | Sign in for TTM |
| Profit before tax | 187 Cr | 282 Cr | 295 Cr | 330 Cr | 358 Cr | Sign in for TTM |
| Tax % | 26.0% | 24.6% | 26.0% | 26.0% | 21.4% | Sign in for TTM |
| Net profit | 139 Cr | 212 Cr | 218 Cr | 244 Cr | 282 Cr | Sign in for TTM |
| EPS (₹) | ₹14.75 | ₹20.89 | ₹21.38 | ₹23.97 | ₹27.41 | Sign in for TTM |
| Dividend payout % | 6.7% | 9.6% | 14.1% | 12.5% | 10.8% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity capital | 105 Cr | 102 Cr | 102 Cr | 102 Cr | 102 Cr |
| Reserves | 498 Cr | 958 Cr | 1,157 Cr | 1,367 Cr | 1,547 Cr |
| Borrowings | 42 Cr | — | — | — | — |
| Other liabilities | 648 Cr | 711 Cr | 905 Cr | 902 Cr | 1,111 Cr |
| Total liabilities | 1,296 Cr | 1,776 Cr | 2,170 Cr | 2,377 Cr | 2,775 Cr |
| Fixed assets (net) | 854 Cr | 928 Cr | 1,249 Cr | 1,388 Cr | 1,562 Cr |
| CWIP | 5 Cr | 21 Cr | 14 Cr | 28 Cr | 76 Cr |
| Investments | 22 Cr | 58 Cr | 308 Cr | 571 Cr | 404 Cr |
| Loans & advances | 0 Cr | 0 Cr | 0 Cr | 3 Cr | 4 Cr |
| Inventories | 15 Cr | 19 Cr | 24 Cr | 28 Cr | 42 Cr |
| Trade receivables | 40 Cr | 58 Cr | 70 Cr | 77 Cr | 103 Cr |
| Cash & bank | 10 Cr | 15 Cr | 10 Cr | 20 Cr | 34 Cr |
| Other assets | 350 Cr | 677 Cr | 496 Cr | 263 Cr | 550 Cr |
| Total assets | 1,296 Cr | 1,776 Cr | 2,170 Cr | 2,377 Cr | 2,775 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Cash from operating activity | 224 Cr | 327 Cr | 321 Cr | 396 Cr | 420 Cr |
| Cash from investing | -175 Cr | -465 Cr | -226 Cr | -268 Cr | -259 Cr |
| Cash from financing | -44 Cr | 143 Cr | -102 Cr | -118 Cr | -147 Cr |
| Net cash flow | 4 Cr | 5 Cr | -7 Cr | 10 Cr | 14 Cr |
| Free cash flow (OCF − Capex) | 162 Cr | 186 Cr | -32 Cr | 250 Cr | 203 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| ROCE % | 37.1% | 31.6% | 28.0% | 27.3% | 26.2% |
| ROE % | 22.8% | 19.8% | 17.2% | 16.5% | 16.7% |
| Debtor days | 15 | 18 | 20 | 19 | 22 |
| Inventory days | 28 | 43 | 53 | 51 | 67 |
| Days payable | 120 | 194 | 180 | 170 | 161 |
| Cash conversion cycle | -78 | -133 | -107 | -100 | -72 |
| Debt / equity | 0.00 | 0.00 | — | — | — |
| Current ratio | 2.32 | 3.35 | 4.16 | 5.53 | 3.59 |
| Net debt / EBITDA | 0.00 | -0.04 | -0.02 | -0.04 | -0.06 |
Compare with peers
Loading peers…